Aravive Inc (DELISTED) (ARAV:DL)
0.0401
0.00 (0.00%)
USD |
NASDAQ |
Feb 07, 16:00
Aravive Total Liabilities (Quarterly): 11.35M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 11.35M |
| June 30, 2023 | 45.55M |
| March 31, 2023 | 81.66M |
| December 31, 2022 | 51.50M |
| September 30, 2022 | 27.18M |
| June 30, 2022 | 25.82M |
| March 31, 2022 | 34.67M |
| December 31, 2021 | 25.56M |
| September 30, 2021 | 22.46M |
| June 30, 2021 | 21.17M |
| March 31, 2021 | 18.55M |
| December 31, 2020 | 19.66M |
| September 30, 2020 | 11.86M |
| June 30, 2020 | 11.57M |
| March 31, 2020 | 12.54M |
| December 31, 2019 | 13.07M |
| September 30, 2019 | 15.06M |
| June 30, 2019 | 13.88M |
| March 31, 2019 | 17.10M |
| December 31, 2018 | 9.525M |
| Date | Value |
|---|---|
| September 30, 2018 | 10.45M |
| June 30, 2018 | 11.36M |
| March 31, 2018 | 10.48M |
| December 31, 2017 | 11.02M |
| September 30, 2017 | 86.33M |
| June 30, 2017 | 72.90M |
| March 31, 2017 | 62.82M |
| December 31, 2016 | 54.50M |
| September 30, 2016 | 54.21M |
| June 30, 2016 | 8.435M |
| March 31, 2016 | 9.848M |
| December 31, 2015 | 8.827M |
| September 30, 2015 | 7.388M |
| June 30, 2015 | 7.309M |
| March 31, 2015 | 7.82M |
| December 31, 2014 | 6.925M |
| September 30, 2014 | 4.289M |
| June 30, 2014 | 5.187M |
| March 31, 2014 | 5.458M |
| December 31, 2013 | 4.478M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
11.35M
Minimum
Sep 2023
81.66M
Maximum
Mar 2023
25.73M
Average
20.41M
Median
Total Liabilities (Quarterly) Benchmarks
| Esperion Therapeutics Inc | 667.36M |
| Processa Pharmaceuticals Inc | 1.061M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 24.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.05M |
| Shareholders Equity (Quarterly) | 1.701M |
| Current Ratio | 0.978 |